Skip to main content

Drug combos for glioblastoma

May. 3, 2016, 8:00 AM

(iStock)

Glioblastoma, an aggressive brain tumor, frequently involves aberrant activation of the growth signaling EGF receptor (EGFR). However, inhibitors of EGFR – which are therapeutically effective against other types of EGFR-driven cancer – have limited clinical benefits against glioblastoma.

Jialiang Wang, Ph.D., and colleagues examined whether activation of another growth signaling pathway confers resistance to EGFR inhibitors in glioblastoma. They showed, using patient-derived glioblastoma cell lines, that activation of the insulin receptor (InsR) and insulin-like growth factor 1 receptor (IGF1R) protected a majority of cell lines from the EGFR inhibitor gefitinib. A combination of gefitinib and a dual InsR/IGF1R inhibitor was more effective than either agent alone against glioblastoma xenograft tumors in a mouse model.

The findings, reported in the April 1 issue of Clinical Cancer Research, suggest that activation of the InsR/IGF1R pathway confers resistance to EGFR inhibitors in glioblastoma. Combining therapies that block both pathways may be a promising treatment for EGFR-dependent glioblastoma.

This research was supported in part by the Southeastern Brain Tumor Foundation, the Voice Against Brain Cancer Foundation, and a grant from the National Cancer Institute (CA166492).

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to aliquots@vanderbilt.edu

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more